Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine
AssigneeIntervet International B.V.
InventorsMaarten Hendrik Witvliet, Jozef Franciscus Maria Smeets, Keith Redhead
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a vaccine comprising Clostridium perfringens type C bacterium for protecting swine against Clostridium perfringens type A infection.
Claims12
1-12. (canceled)
A method for protecting swine against Clostridium perfringens type A infection, comprising administering a vaccine comprising an immunogenically effective amount of Clostridium perfringens type C antigen.
A method for protecting piglets against Clostridium perfringens type A infection, comprising administering an immunogenically effective amount of Clostridium perfringens antigen to the mother of the piglets.
Dependencies are inferred from the claim text.